Can Walmart make us healthier? Prescription drug prices and health care utilization

J Health Econ. 2015 Dec:44:37-53. doi: 10.1016/j.jhealeco.2015.07.005. Epub 2015 Aug 8.

Abstract

This paper analyzes how prices in the retail pharmaceutical market affect health care utilization. Specifically, I study the impact of Walmart's $4 Prescription Drug Program on utilization of antihypertensive drugs and on hospitalizations for conditions amenable to drug therapy. Identification relies on the change in the availability of cheap drugs introduced by Walmart's program, exploiting variation in the distance to the nearest Walmart across ZIP codes in a difference-in-differences framework. I find that living close to a source of cheap drugs increases utilization of antihypertensive medications by 7 percent and decreases the probability of an avoidable hospitalization by 6.2 percent.

Keywords: Avoidable hospitalizations; Health care utilization; Hospitalizations; Prescription drugs; Walmart.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chronic Disease / drug therapy
  • Chronic Disease / economics*
  • Commerce / economics
  • Commerce / trends
  • Drugs, Generic / economics*
  • Drugs, Generic / therapeutic use
  • Female
  • Health Services Accessibility
  • Hospitalization / economics*
  • Hospitalization / trends
  • Humans
  • Insurance, Health / classification
  • Insurance, Health / economics*
  • Male
  • Middle Aged
  • Patient Acceptance of Health Care / statistics & numerical data*
  • Pharmacies / economics*
  • Pharmacies / trends
  • Prescription Fees / trends*
  • United States

Substances

  • Drugs, Generic